FDA — authorised 29 September 2022
- Marketing authorisation holder: AMYLYX
- Status: approved
🇺🇸 Relyvrio in United States
FDA authorised Relyvrio on 29 September 2022
Marketing authorisation
Relyvrio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Relyvrio approved in United States?
Yes. FDA authorised it on 29 September 2022.
Who is the marketing authorisation holder for Relyvrio in United States?
AMYLYX holds the US marketing authorisation.